Showing results (1851-1860 of 2,232) with videos related to

Sort By:
Pageof 224
Scientific Reports|March 25, 2017
Targeting to the non-genomic activity of retinoic acid receptor-gamma by acacetin in hepatocellular carcinomaWenjun Zeng, Chunyun Zhang, Hongwei Cheng, et al.
Nature Methods|February 10, 2015
Mapping native disulfide bonds at a proteome scaleShan Lu, Sheng-Bo Fan, Bing Yang, et al.
Guang Pu Xue Yu Guang Pu Fen Xi = Guang Pu|January 5, 2013
[Infrared multiphoton quantum cutting phenomena of rare earth materials]Xiao-Bo Chen, Guo-Jian Yang, Yun-Zhi Zhang, et al.
Plos One|January 26, 2012
Bisulfite sequencing reveals that Aspergillus flavus holds a hollow in DNA methylationSi-Yang Liu, Jian-Qing Lin, Hong-Long Wu, et al.
Lung Cancer (Amsterdam, Netherlands)|August 27, 2019
Safety and efficacy of pembrolizumab monotherapy in elderly patients with PD-L1-positive advanced non-small-cell lung cancer: Pooled analysis from the KEYNOTE-010, KEYNOTE-024, and KEYNOTE-042 studiesKaname Nosaki, Hideo Saka, Yukio Hosomi, et al.
Oncoimmunology|November 18, 2017
EGFR mutation correlates with uninflamed phenotype and weak immunogenicity, causing impaired response to PD-1 blockade in non-small cell lung cancerZhong-Yi Dong, Jia-Tao Zhang, Si-Yang Liu, et al.
Thoracic Cancer|July 13, 2022
Dynamic 18 F-FDG PET/CT can predict the major pathological response to neoadjuvant immunotherapy in non-small cell lung cancerZhi-Yong Chen, Rui Fu, Xiao-Yue Tan, et al.
Chinese Journal of Cancer|June 29, 2017
Different dissecting orders of the pulmonary bronchus and vessels during right upper lobectomy are associated with surgical feasibility and postoperative recovery for lung cancer patientsHao-Ran Zhai, Xue-Ning Yang, Qiang Nie, et al.
Fitoterapia|April 18, 2026
Diarylheptanoid derivatives with α-synuclein aggregation inhibitory activities from the rhizome of Alpinia officinarumXue-Yi Li, Jun-Feng She, Qiu-Mei Lv, et al.
Medical Oncology (Northwood, London, England)|April 5, 2011
Posttreatment plasma VEGF levels may be associated with the overall survival of patients with advanced non-small cell lung cancer treated with bevacizumab plus chemotherapyShe-Juan An, Yi-Sheng Huang, Zhi-Hong Chen, et al.
Pageof 224